Copyright Reports & Markets. All rights reserved.

Global Microfluidics’ as well as Point-of-care(POC) Technology Market Research Report 2021

Request for Sample of this report
Buy now

1 Microfluidics’ as well as Point-of-care(POC) Technology Market Overview

  • 1.1 Product Overview and Scope of Microfluidics’ as well as Point-of-care(POC) Technology
  • 1.2 Microfluidics’ as well as Point-of-care(POC) Technology Segment by Type
    • 1.2.1 Global Microfluidics’ as well as Point-of-care(POC) Technology Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Laminar Flow
    • 1.2.3 Liquid Drop
  • 1.3 Microfluidics’ as well as Point-of-care(POC) Technology Segment by Application
    • 1.3.1 Microfluidics’ as well as Point-of-care(POC) Technology Sales Comparison by Application: (2021-2027)
    • 1.3.2 Cancer
    • 1.3.3 Heart Disease
    • 1.3.4 Malaria
    • 1.3.5 AIDS, Syphilis
  • 1.4 Global Microfluidics’ as well as Point-of-care(POC) Technology Market Size Estimates and Forecasts
    • 1.4.1 Global Microfluidics’ as well as Point-of-care(POC) Technology Revenue 2016-2027
    • 1.4.2 Global Microfluidics’ as well as Point-of-care(POC) Technology Sales 2016-2027
    • 1.4.3 Microfluidics’ as well as Point-of-care(POC) Technology Market Size by Region: 2016 Versus 2021 Versus 2027

2 Microfluidics’ as well as Point-of-care(POC) Technology Market Competition by Manufacturers

  • 2.1 Global Microfluidics’ as well as Point-of-care(POC) Technology Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Microfluidics’ as well as Point-of-care(POC) Technology Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Microfluidics’ as well as Point-of-care(POC) Technology Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Microfluidics’ as well as Point-of-care(POC) Technology Manufacturing Sites, Area Served, Product Type
  • 2.5 Microfluidics’ as well as Point-of-care(POC) Technology Market Competitive Situation and Trends
    • 2.5.1 Microfluidics’ as well as Point-of-care(POC) Technology Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Microfluidics’ as well as Point-of-care(POC) Technology Players Market Share by Revenue
    • 2.5.3 Global Microfluidics’ as well as Point-of-care(POC) Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Microfluidics’ as well as Point-of-care(POC) Technology Retrospective Market Scenario by Region

  • 3.1 Global Microfluidics’ as well as Point-of-care(POC) Technology Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Microfluidics’ as well as Point-of-care(POC) Technology Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Microfluidics’ as well as Point-of-care(POC) Technology Market Facts & Figures by Country
    • 3.3.1 North America Microfluidics’ as well as Point-of-care(POC) Technology Sales by Country
    • 3.3.2 North America Microfluidics’ as well as Point-of-care(POC) Technology Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Microfluidics’ as well as Point-of-care(POC) Technology Market Facts & Figures by Country
    • 3.4.1 Europe Microfluidics’ as well as Point-of-care(POC) Technology Sales by Country
    • 3.4.2 Europe Microfluidics’ as well as Point-of-care(POC) Technology Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Microfluidics’ as well as Point-of-care(POC) Technology Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Microfluidics’ as well as Point-of-care(POC) Technology Sales by Region
    • 3.5.2 Asia Pacific Microfluidics’ as well as Point-of-care(POC) Technology Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Microfluidics’ as well as Point-of-care(POC) Technology Market Facts & Figures by Country
    • 3.6.1 Latin America Microfluidics’ as well as Point-of-care(POC) Technology Sales by Country
    • 3.6.2 Latin America Microfluidics’ as well as Point-of-care(POC) Technology Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Microfluidics’ as well as Point-of-care(POC) Technology Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Microfluidics’ as well as Point-of-care(POC) Technology Sales by Country
    • 3.7.2 Middle East and Africa Microfluidics’ as well as Point-of-care(POC) Technology Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Microfluidics’ as well as Point-of-care(POC) Technology Historic Market Analysis by Type

  • 4.1 Global Microfluidics’ as well as Point-of-care(POC) Technology Sales Market Share by Type (2016-2021)
  • 4.2 Global Microfluidics’ as well as Point-of-care(POC) Technology Revenue Market Share by Type (2016-2021)
  • 4.3 Global Microfluidics’ as well as Point-of-care(POC) Technology Price by Type (2016-2021)

5 Global Microfluidics’ as well as Point-of-care(POC) Technology Historic Market Analysis by Application

  • 5.1 Global Microfluidics’ as well as Point-of-care(POC) Technology Sales Market Share by Application (2016-2021)
  • 5.2 Global Microfluidics’ as well as Point-of-care(POC) Technology Revenue Market Share by Application (2016-2021)
  • 5.3 Global Microfluidics’ as well as Point-of-care(POC) Technology Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Illumina
    • 6.1.1 Illumina Corporation Information
    • 6.1.2 Illumina Description and Business Overview
    • 6.1.3 Illumina Microfluidics’ as well as Point-of-care(POC) Technology Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Illumina Product Portfolio
    • 6.1.5 Illumina Recent Developments/Updates
  • 6.2 BioMérieux
    • 6.2.1 BioMérieux Corporation Information
    • 6.2.2 BioMérieux Description and Business Overview
    • 6.2.3 BioMérieux Microfluidics’ as well as Point-of-care(POC) Technology Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 BioMérieux Product Portfolio
    • 6.2.5 BioMérieux Recent Developments/Updates
  • 6.3 Abbott Laboratories
    • 6.3.1 Abbott Laboratories Corporation Information
    • 6.3.2 Abbott Laboratories Description and Business Overview
    • 6.3.3 Abbott Laboratories Microfluidics’ as well as Point-of-care(POC) Technology Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Abbott Laboratories Product Portfolio
    • 6.3.5 Abbott Laboratories Recent Developments/Updates
  • 6.4 Cepheid
    • 6.4.1 Cepheid Corporation Information
    • 6.4.2 Cepheid Description and Business Overview
    • 6.4.3 Cepheid Microfluidics’ as well as Point-of-care(POC) Technology Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Cepheid Product Portfolio
    • 6.4.5 Cepheid Recent Developments/Updates
  • 6.5 Affymetrix (Thermo Fisher)
    • 6.5.1 Affymetrix (Thermo Fisher) Corporation Information
    • 6.5.2 Affymetrix (Thermo Fisher) Description and Business Overview
    • 6.5.3 Affymetrix (Thermo Fisher) Microfluidics’ as well as Point-of-care(POC) Technology Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Affymetrix (Thermo Fisher) Product Portfolio
    • 6.5.5 Affymetrix (Thermo Fisher) Recent Developments/Updates
  • 6.6 Roche Holding AG
    • 6.6.1 Roche Holding AG Corporation Information
    • 6.6.2 Roche Holding AG Description and Business Overview
    • 6.6.3 Roche Holding AG Microfluidics’ as well as Point-of-care(POC) Technology Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Roche Holding AG Product Portfolio
    • 6.6.5 Roche Holding AG Recent Developments/Updates
  • 6.7 MGI(BGI)
    • 6.6.1 MGI(BGI) Corporation Information
    • 6.6.2 MGI(BGI) Description and Business Overview
    • 6.6.3 MGI(BGI) Microfluidics’ as well as Point-of-care(POC) Technology Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 MGI(BGI) Product Portfolio
    • 6.7.5 MGI(BGI) Recent Developments/Updates
  • 6.8 10x Genomics
    • 6.8.1 10x Genomics Corporation Information
    • 6.8.2 10x Genomics Description and Business Overview
    • 6.8.3 10x Genomics Microfluidics’ as well as Point-of-care(POC) Technology Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 10x Genomics Product Portfolio
    • 6.8.5 10x Genomics Recent Developments/Updates
  • 6.9 Abaxis (Zoetis)
    • 6.9.1 Abaxis (Zoetis) Corporation Information
    • 6.9.2 Abaxis (Zoetis) Description and Business Overview
    • 6.9.3 Abaxis (Zoetis) Microfluidics’ as well as Point-of-care(POC) Technology Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Abaxis (Zoetis) Product Portfolio
    • 6.9.5 Abaxis (Zoetis) Recent Developments/Updates
  • 6.10 Siemens Healthineers
    • 6.10.1 Siemens Healthineers Corporation Information
    • 6.10.2 Siemens Healthineers Description and Business Overview
    • 6.10.3 Siemens Healthineers Microfluidics’ as well as Point-of-care(POC) Technology Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Siemens Healthineers Product Portfolio
    • 6.10.5 Siemens Healthineers Recent Developments/Updates
  • 6.11 BD(Becton Dickinson)
    • 6.11.1 BD(Becton Dickinson) Corporation Information
    • 6.11.2 BD(Becton Dickinson) Microfluidics’ as well as Point-of-care(POC) Technology Description and Business Overview
    • 6.11.3 BD(Becton Dickinson) Microfluidics’ as well as Point-of-care(POC) Technology Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 BD(Becton Dickinson) Product Portfolio
    • 6.11.5 BD(Becton Dickinson) Recent Developments/Updates
  • 6.12 Agilent Technologies
    • 6.12.1 Agilent Technologies Corporation Information
    • 6.12.2 Agilent Technologies Microfluidics’ as well as Point-of-care(POC) Technology Description and Business Overview
    • 6.12.3 Agilent Technologies Microfluidics’ as well as Point-of-care(POC) Technology Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Agilent Technologies Product Portfolio
    • 6.12.5 Agilent Technologies Recent Developments/Updates
  • 6.13 Boehringer Ingelheim
    • 6.13.1 Boehringer Ingelheim Corporation Information
    • 6.13.2 Boehringer Ingelheim Microfluidics’ as well as Point-of-care(POC) Technology Description and Business Overview
    • 6.13.3 Boehringer Ingelheim Microfluidics’ as well as Point-of-care(POC) Technology Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Boehringer Ingelheim Product Portfolio
    • 6.13.5 Boehringer Ingelheim Recent Developments/Updates
  • 6.14 Abaxis (Zoetis)
    • 6.14.1 Abaxis (Zoetis) Corporation Information
    • 6.14.2 Abaxis (Zoetis) Microfluidics’ as well as Point-of-care(POC) Technology Description and Business Overview
    • 6.14.3 Abaxis (Zoetis) Microfluidics’ as well as Point-of-care(POC) Technology Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Abaxis (Zoetis) Product Portfolio
    • 6.14.5 Abaxis (Zoetis) Recent Developments/Updates

7 Microfluidics’ as well as Point-of-care(POC) Technology Manufacturing Cost Analysis

  • 7.1 Microfluidics’ as well as Point-of-care(POC) Technology Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Microfluidics’ as well as Point-of-care(POC) Technology
  • 7.4 Microfluidics’ as well as Point-of-care(POC) Technology Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Microfluidics’ as well as Point-of-care(POC) Technology Distributors List
  • 8.3 Microfluidics’ as well as Point-of-care(POC) Technology Customers

9 Microfluidics’ as well as Point-of-care(POC) Technology Market Dynamics

  • 9.1 Microfluidics’ as well as Point-of-care(POC) Technology Industry Trends
  • 9.2 Microfluidics’ as well as Point-of-care(POC) Technology Growth Drivers
  • 9.3 Microfluidics’ as well as Point-of-care(POC) Technology Market Challenges
  • 9.4 Microfluidics’ as well as Point-of-care(POC) Technology Market Restraints

10 Global Market Forecast

  • 10.1 Microfluidics’ as well as Point-of-care(POC) Technology Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Microfluidics’ as well as Point-of-care(POC) Technology by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Microfluidics’ as well as Point-of-care(POC) Technology by Type (2022-2027)
  • 10.2 Microfluidics’ as well as Point-of-care(POC) Technology Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Microfluidics’ as well as Point-of-care(POC) Technology by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Microfluidics’ as well as Point-of-care(POC) Technology by Application (2022-2027)
  • 10.3 Microfluidics’ as well as Point-of-care(POC) Technology Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Microfluidics’ as well as Point-of-care(POC) Technology by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Microfluidics’ as well as Point-of-care(POC) Technology by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Laminar Flow
    Liquid Drop

    Segment by Application
    Cancer
    Heart Disease
    Malaria
    AIDS, Syphilis

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Illumina
    BioMérieux
    Abbott Laboratories
    Cepheid
    Affymetrix (Thermo Fisher)
    Roche Holding AG
    MGI(BGI)
    10x Genomics
    Abaxis (Zoetis)
    Siemens Healthineers
    BD(Becton Dickinson)
    Agilent Technologies
    Boehringer Ingelheim
    Abaxis (Zoetis)

    Buy now